These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 19110275)
1. Against: No surgery for stuttering priapism. Burnett AL J Urol; 2009 Feb; 181(2):450-1. PubMed ID: 19110275 [No Abstract] [Full Text] [Related]
2. For: Surgery for stuttering priapism. Carson CC J Urol; 2009 Feb; 181(2):449-50. PubMed ID: 19070870 [No Abstract] [Full Text] [Related]
3. Penile prosthesis insertion for acute priapism. Tausch TJ; Mauck R; Zhao LC; Morey AF Urol Clin North Am; 2013 Aug; 40(3):421-5. PubMed ID: 23905940 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in the medical and surgical treatment of priapism. Shrewsberry A; Weiss A; Ritenour CW Curr Urol Rep; 2010 Nov; 11(6):405-13. PubMed ID: 20878277 [TBL] [Abstract][Full Text] [Related]
5. Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case. Finley DS J Sex Med; 2008 Dec; 5(12):2963-6. PubMed ID: 18823322 [TBL] [Abstract][Full Text] [Related]
6. Insights of priapism mechanism and rationale treatment for recurrent priapism. Yuan J; Desouza R; Westney OL; Wang R Asian J Androl; 2008 Jan; 10(1):88-101. PubMed ID: 18087648 [TBL] [Abstract][Full Text] [Related]
7. Idiopathic stuttering priapism: recovery of detumescence mechanism with temporal use of antiandrogen. Yamashita N; Hisasue S; Kato R; Masumori N; Takahashi A; Itoh N; Tsukamoto T Urology; 2004 Jun; 63(6):1182-4. PubMed ID: 15183981 [TBL] [Abstract][Full Text] [Related]
8. Distal cavernosum-glans shunts for ischemic priapism. Lue TF; Pescatori ES J Sex Med; 2006 Jul; 3(4):749-752. PubMed ID: 16839333 [No Abstract] [Full Text] [Related]
9. Guideline of guidelines: priapism. Muneer A; Ralph D BJU Int; 2017 Feb; 119(2):204-208. PubMed ID: 27860090 [No Abstract] [Full Text] [Related]
10. T-shaped Shunt With Intracavernosal Tunneling for a Pediatric Case of Refractory Ischemic Priapism. Seideman CA; Gitlin JS Urology; 2017 Dec; 110():220-222. PubMed ID: 27693479 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. Burnett AL; Bivalacqua TJ; Champion HC; Musicki B J Sex Med; 2006 Nov; 3(6):1077-1084. PubMed ID: 17100941 [TBL] [Abstract][Full Text] [Related]
12. [Strategies for the treatment and prevention of priapism in children]. Qin F; Qian SQ; Yuan JH Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):1001-6. PubMed ID: 24343090 [TBL] [Abstract][Full Text] [Related]
13. [Arterialization of the penis--a new method for the treatment of ischemic priapism]. Shcheplev PA; Gerlivanov AB; Kudriavtsev IuV Khirurgiia (Sofiia); 1989; 42(5):96-100. PubMed ID: 2625931 [No Abstract] [Full Text] [Related]
14. Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation. Pierorazio PM; Bivalacqua TJ; Burnett AL J Androl; 2011; 32(4):371-4. PubMed ID: 21127306 [TBL] [Abstract][Full Text] [Related]
15. Immediate Placement of a Penile Prosthesis as First-line Treatment for the Management of Ischaemic Priapism. Muneer A; Ralph DJ Eur Urol Focus; 2019 Jul; 5(4):529-530. PubMed ID: 30691962 [TBL] [Abstract][Full Text] [Related]
16. Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy. Broderick GA J Sex Med; 2012 Jan; 9(1):88-103. PubMed ID: 21699659 [TBL] [Abstract][Full Text] [Related]
17. Immediate Placement of Penile Prosthesis for the Management of Ischemic Priapism as First-line Treatment. Yafi FA; Hellstrom WJG Eur Urol Focus; 2019 Jul; 5(4):531-532. PubMed ID: 30639251 [TBL] [Abstract][Full Text] [Related]
18. 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME). Shindel AW J Sex Med; 2009 Jul; 6(7):1794-808; quiz 1793, 1809-10. PubMed ID: 19575771 [TBL] [Abstract][Full Text] [Related]
19. Beneficial Effect of the Nitric Oxide Donor Compound 3-(1,3-Dioxoisoindolin-2-yl)Benzyl Nitrate on Dysregulated Phosphodiesterase 5, NADPH Oxidase, and Nitrosative Stress in the Sickle Cell Mouse Penis: Implication for Priapism Treatment. Silva FH; Karakus S; Musicki B; Matsui H; Bivalacqua TJ; Dos Santos JL; Costa FF; Burnett AL J Pharmacol Exp Ther; 2016 Nov; 359(2):230-237. PubMed ID: 27540002 [TBL] [Abstract][Full Text] [Related]